NAT9

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, NAT9 mutation is significantly associated with the RNA expression of many other genes, with 51 significant associations in total. BLCA shows the largest number of these associations.

The most reproducible NAT9-associated genes across cancer lineages are TP73-AS2, ATP6V0CP2, and CFTRP3. Each is linked with NAT9 in more than 1 cancer types. Because this analysis shows association rather than direction, both NAT9-to-partner and partner-to-NAT9 results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, TP73-AS2 grouped by NAT9-low versus NAT9-high in SKCM.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (NAT9→partner) and Y-score (partner→NAT9) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
SKCMTP73-AS2 →+0.202+4.628<.001.00432
SKCMATP6V0CP2 →+0.253+4.953<.001.00232
LUADCFTRP3 →+0.263+7.930<.001.00832
BRCAMIR1277 →+0.305+4.800<.001.00632
BLCAUSP29 →+0.016+4.268<.001.00831
BLCARNA5SP453 →+0.453+4.497<.001.00931
Each partner links to its Q-omics profile. Showing the 6 strongest of 51 associations by consensus.

TP73-AS2 by NAT9 expression — SKCM

Box plot of TP73-AS2 in NAT9-low vs NAT9-high samples in SKCM.

Explore this box plot interactively →

Exploration